LFG
AMED

Larson Financial Group’s Amedisys AMED Stock Holding History

Larson Financial Group’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-21
Closed -$2.07K – 3435
2025
Q2 		$2.07K Buy
21
+4
+24% +$378 ﹤0.01% 2394
2025
Q1 		$1.57K Buy
+17
New +$1.57K ﹤0.01% 2245
2023
Q4 		– Sell
-16
Closed -$1.49K – 1795
2023
Q3 		$1.49K Buy
+16
New +$1.48K ﹤0.01% 1417

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Larson Financial Group's AMED Position: Q3 2025 in Review

Larson Financial Group sold out of Amedisys (AMED) in Q3 2025, closing a stake of 21 shares — an estimated $2.07K sold.

Larson Financial Group first reported a position in AMED in Q3 2023 and held it in 3 quarters. The position peaked at $2.07K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Larson Financial Group reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Larson Financial Group sold 21 Amedisys shares in Q3 2025, an estimated $2.07K.
  • Larson Financial Group first reported a position in Amedisys in Q3 2023 and held it in 3 quarters.
  • Larson Financial Group's Amedisys position peaked at $2.07K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Larson Financial Group's 13F filing for Q3 2025, filed 14 Nov 2025.